Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 6
2004 4
2005 3
2006 6
2007 5
2008 3
2009 7
2010 3
2011 6
2012 12
2013 15
2014 12
2015 6
2016 15
2017 22
2018 27
2019 29
2020 29
2021 16
2022 29
2023 34
2024 28
2025 30
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

313 results

Results by year

Filters applied: . Clear all
Page 1
Données et preuves en vie réelle dans l’évaluation des technologies de santé : dans quels cas sont-elles complémentaires, substitutives, ou les seules sources de données par rapport aux essais cliniques ?
de Pouvourville G, Armoiry X, Lavorel A, Bilbault P, Maugendre P, Bensimon L, Beziz D, Blin P, Borget I, Bouée S, Collignon C, Dervaux B, Durand-Zaleski I, Julien M, de Léotoing L, Majed L, Martelli N, Séjourné T, Viprey M. de Pouvourville G, et al. Among authors: durand zaleski i. Therapie. 2023 Jan-Feb;78(1):66-80. doi: 10.1016/j.therap.2022.10.067. Epub 2022 Oct 29. Therapie. 2023. PMID: 36446648 French. No abstract available.
Effect of Prehabilitation Before Total Knee Replacement for Knee Osteoarthritis on Functional Outcomes: A Randomized Clinical Trial.
Nguyen C, Boutron I, Roren A, Anract P, Beaudreuil J, Biau D, Boisgard S, Daste C, Durand-Zaleski I, Eschalier B, Gil C, Lefèvre-Colau MM, Nizard R, Perrodeau É, Rabetrano H, Richette P, Sanchez K, Zalc J, Coudeyre E, Rannou F. Nguyen C, et al. Among authors: durand zaleski i. JAMA Netw Open. 2022 Mar 1;5(3):e221462. doi: 10.1001/jamanetworkopen.2022.1462. JAMA Netw Open. 2022. PMID: 35262716 Free PMC article. Clinical Trial.
Evaluation of mechanical thrombectomy in acute ischemic stroke related to a distal arterial occlusion: A randomized controlled trial.
Clarençon F, Durand-Zaleski I, Premat K, Baptiste A, Chabert E, Ferrier A, Labeyrie MA, Reiner P, Spelle L, Denier C, Tuilier T, Hosseini H, Rodriguez-Régent C, Turc G, Fauché C, Lamy M, Lapergue B, Consoli A, Barbier C, Boulanger M, Bricout N, Henon H, Gory B, Richard S, Rouchaud A, Macian-Montoro F, Eker O, Cho TH, Soize S, Moulin S, Gentric JC, Timsit S, Darcourt J, Albucher JF, Janot K, Annan M, Pico F, Costalat V, Arquizan C, Marnat G, Sibon I, Pop R, Wolff V, Shotar E, Lenck S, Sourour NA, Radenne A, Alamowitch S, Dechartres A. Clarençon F, et al. Among authors: durand zaleski i. Int J Stroke. 2024 Mar;19(3):367-372. doi: 10.1177/17474930231205213. Epub 2023 Oct 12. Int J Stroke. 2024. PMID: 37740419 Clinical Trial.
Comment la réforme de la T2A peut-elle permettre de financer des produits de santé innovants ?
Armoiry X, Saidani N, Aoustin M, Camus D, Cano-Chancel A, Carlier S, Degrassat-Théas A, Epis de Fleurian AA, Grumblat A, Lavorel A, Lesaignoux M, Martin T, Michaud A, Morizot J, Préaubert N, Riche VP, Durand Zaleski I. Armoiry X, et al. Among authors: durand zaleski i. Therapie. 2025 Jan-Feb;80(1):61-76. doi: 10.1016/j.therap.2024.11.001. Epub 2024 Nov 5. Therapie. 2025. PMID: 39613555 Free article. French. No abstract available.
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F, Pintado C, Chidiac C, Chas J, Charbonneau P, Delaugerre C, Suzan-Monti M, Loze B, Fonsart J, Peytavin G, Cheret A, Timsit J, Girard G, Lorente N, Préau M, Rooney JF, Wainberg MA, Thompson D, Rozenbaum W, Doré V, Marchand L, Simon MC, Etien N, Aboulker JP, Meyer L, Delfraissy JF; ANRS IPERGAY Study Group. Molina JM, et al. N Engl J Med. 2015 Dec 3;373(23):2237-46. doi: 10.1056/NEJMoa1506273. Epub 2015 Dec 1. N Engl J Med. 2015. PMID: 26624850 Free article. Clinical Trial.
Dispositif médical à usage professionnel : quelle évaluation, quel financement ?
Riche VP, de Place L, Armoiry X, Camus D, Charle-Maachi C, Deslandes M, Espagno C, Fabiano J, Farah L, Grajoszex M, Johns E, Josseran A, Michaud A, Potel L, Rematier P, Riquier T, Vercamer V, Verrier L, Vicaut E, Durand-Zaleski I. Riche VP, et al. Among authors: durand zaleski i. Therapie. 2026 Jan-Feb;81(1):42-55. doi: 10.1016/j.therap.2025.10.007. Epub 2025 Dec 19. Therapie. 2026. PMID: 41483958 Free article. French. No abstract available.
Place des mesures rapportées par les patients (PROMS/PREMS) dans l’évaluation et la valorisation des technologies de santé en France.
Roussel C, Chassany O, Durand-Zaleski I, Josseran A, Alter L, Auquier P, Bourguignon S, Cachoux J, Desforges C, Fernandez J, Gaudin AF, Germe AF, Haenel E, Olivier P, Maillard N, Naïditch N, Nguyen T, Péan C, Rumeau-Pichon C, Sales JP, Schmidely N, Tuppin P, Vray M. Roussel C, et al. Among authors: durand zaleski i. Therapie. 2022 Jan-Feb;77(1):89-102. doi: 10.1016/j.therap.2022.01.007. Epub 2022 Jan 13. Therapie. 2022. PMID: 35115142 French. No abstract available.
Reply.
Nahon P, Seror O, Durand-Zaleski I. Nahon P, et al. Among authors: durand zaleski i. Hepatology. 2017 Jul;66(1):298-299. doi: 10.1002/hep.29174. Epub 2017 May 26. Hepatology. 2017. PMID: 28318039 No abstract available.
313 results